Major Mouse Testing Program Aims To Fast Track Regenerative Medicine

“A significant problem with longevity research and testing in the past has been a lack of robust results. Small animal cohorts and questionable husbandry, combined with poor metrics or protocols, have lead to inconsistent or even conflicting results. In a field as poorly funded as longevity research currently is, we cannot afford to waste money and effort on flawed experiments, that do not provide solid evidence of efficacy and high potential for human clinical trials.

The Major mouse testing program is working to redress this situation with the help of an international team of dedicated researchers. We hope to deliver the kind of consistent and quality data required to provide definite confirmation of longevity interventions. We plan to initiate large scale testing on already aged mice – the approximate equivalent of a human aged sixty. This means we can produce consistent, accurate and notably faster results to drive progress.”

Read full text at Singularity Weblog